The National Institute for Communicable Diseases (NICD) is the national public health insitute for South Africa. It provides reference microbiology,virology,epidemiology, surveillance and public health research to support the government’s response to communicable disease threats.
The NICD is organised into functional Centres, bringing together expertise in both reference microbiology and epidemiology to enable an intergrated public health response to communicable disease threats.
The NICD primarily supports the programmes of the National and Provincial Departments of Health. As well as national support, the NICD also provides public health services such as collaborating laboratory or regional reference laboratory functions for global programmes of the World Health Organisation (WHO)
The NICD has established co-operatives agreements with partner national public health institutions such as the Center for Disease Control (CDC) and NIH/NIAID of the USA, the European Centre for Disease Control (ECDC) and the Health Protection Agency (HPA) of the United Kingdom, as well as other internationally recognised public health insitutions.
Jaishree Raman, National Institute for Communicable Diseases
South Africa is one of the few malaria-endemic countries in Africa that did not see a major upsurge in malaria cases caused by COVID-related disruptions.
A pesar de la pandemia, las disparidades y las estructuras de poder desiguales en la salud mundial siguen intactas. Será difícil afrontar nuevos desafíos globales, como el calentamiento global, si no cambia el sistema.
Mvuyo Makhasi, National Institute for Communicable Diseases; Cheryl Cohen, National Institute for Communicable Diseases, and Sibongile Walaza, University of the Witwatersrand
This is not an alternative to traditional disease surveillance, but a complementary tool.
Cari van Schalkwyk, South African Centre for Epidemiological Modelling & Analysis (SACEMA) ; Harry Moultrie, National Institute for Communicable Diseases, and Juliet Pulliam, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
At this stage, we cannot say anything about the severity of cases with Omicron - either in primary or reinfections.
Une nouvelle lignée de SARS-CoV-2, B.1.1.529, a été identifiée. Baptisée Omicron par l’OMS, qui l’a catégorisé « préoccupant », ce variant a un profil génétique très différent des précédents.
Jaishree Raman, National Institute for Communicable Diseases and Shüné Oliver, National Institute for Communicable Diseases
The South African Malaria Control Programme is one of the few on the continent that is entirely funded by government. The stable source of funding has allowed for steady malaria control interventions.
Countries like the United States, Denmark, Germany, Spain and Switzerland have already vaccinated many millions of adolescents and their experience will guide countries that follow suit.
Jaishree Raman, National Institute for Communicable Diseases and Shüné Oliver, National Institute for Communicable Diseases
The successful development of an effective vaccine against the deadliest form of malaria that is most common in sub-Saharan Africa is indeed a major achievement.
Michelle J. Groome, National Institute for Communicable Diseases and Janusz Paweska, National Institute for Communicable Diseases
De nombreux pays africains ont acquis beaucoup d'xpériences en matière de gestion de épidémies de fièvres hémorragiques virales qu'ils peuvent appliquer à celle du virus à Marburg.
Making vaccines in South Africa by building on the foundation that’s been laid is possible. But only if substantial and sustained investment in human resources and infrastructure becomes a reality.
Michelle J. Groome, National Institute for Communicable Diseases and Janusz Paweska, National Institute for Communicable Diseases
Many African countries are experienced in managing outbreaks of viral haemorrhagic fevers and many of the lessons learnt from the Ebola can be applied to the Marburg outbreak.
Michelle J. Groome, National Institute for Communicable Diseases; Adrian Puren, National Institute for Communicable Diseases, and Harry Moultrie, National Institute for Communicable Diseases
Communities with high vaccine coverage rates are likely to see lower case numbers, hospitalisations and deaths related to COVID-19 compared to those with poor vaccine coverage.
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases